These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1534698)

  • 21. Molecular determinants of agonist and antagonist signaling through the IL-36 receptor.
    Günther S; Sundberg EJ
    J Immunol; 2014 Jul; 193(2):921-30. PubMed ID: 24935927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular permutation of polypeptide chains: implications for protein folding and stability.
    Heinemann U; Hahn M
    Prog Biophys Mol Biol; 1995; 64(2-3):121-43. PubMed ID: 8987381
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression, purification, and biophysical studies of chromodomain proteins.
    Nielsen PR; Callaghan J; Murzin AG; Murzina NV; Laue ED
    Methods Enzymol; 2004; 376():148-70. PubMed ID: 14975304
    [No Abstract]   [Full Text] [Related]  

  • 24. Stability engineering, biophysical, and biological characterization of the myeloid activating receptor immunoglobulin-like transcript 1 (ILT1/LIR-7/LILRA2).
    Chen Y; Chu F; Gao F; Zhou B; Gao GF
    Protein Expr Purif; 2007 Dec; 56(2):253-60. PubMed ID: 17920929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein.
    Carter DB; Deibel MR; Dunn CJ; Tomich CS; Laborde AL; Slightom JL; Berger AE; Bienkowski MJ; Sun FF; McEwan RN
    Nature; 1990 Apr; 344(6267):633-8. PubMed ID: 2139180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport.
    Dwyer DS
    Proteins; 2001 Mar; 42(4):531-41. PubMed ID: 11170207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 1 and related cytokines.
    Flad HD; Kirchner H; Resch K
    Lymphokine Res; 1989; 8(3):227-33. PubMed ID: 2528661
    [No Abstract]   [Full Text] [Related]  

  • 28. New method for protein secondary structure assignment based on a simple topological descriptor.
    Taylor T; Rivera M; Wilson G; Vaisman II
    Proteins; 2005 Aug; 60(3):513-24. PubMed ID: 15887224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.
    Vigers GP; Anderson LJ; Caffes P; Brandhuber BJ
    Nature; 1997 Mar; 386(6621):190-4. PubMed ID: 9062193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homology modeling and molecular dynamics study of NAD-dependent glycerol-3-phosphate dehydrogenase from Trypanosoma brucei rhodesiense, a potential target enzyme for anti-sleeping sickness drug development.
    Zubrzycki IZ
    Biophys J; 2002 Jun; 82(6):2906-15. PubMed ID: 12023213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological properties and clinical importance of interleukin 1].
    Robak T
    Postepy Hig Med Dosw; 1995; 49(2):263-85. PubMed ID: 8657631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 1 as an inflammatory hormone.
    Ohkawara S; Goto F; Yoshinaga M
    Acta Pathol Jpn; 1989 Feb; 39(2):85-100. PubMed ID: 2524152
    [No Abstract]   [Full Text] [Related]  

  • 33. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Ohlsson K; Björk P; Bergenfeldt M; Hageman R; Thompson RC
    Nature; 1990 Dec; 348(6301):550-2. PubMed ID: 2147233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1 and inhibition of interleukin-1 in hemodialysis patients.
    Dinarello CA
    Contrib Nephrol; 1990; 86():48-69; discussion 69-72. PubMed ID: 1706650
    [No Abstract]   [Full Text] [Related]  

  • 35. The interleukin-1/interleukin-1-receptor interaction.
    MacDonald HR; Lowenthal JW
    Ann Inst Pasteur Immunol; 1987; 138(3):482-5. PubMed ID: 2958019
    [No Abstract]   [Full Text] [Related]  

  • 36. Interleukin-1 inhibitors.
    Seckinger P; Dayer JM
    Ann Inst Pasteur Immunol; 1987; 138(3):486-8. PubMed ID: 2958020
    [No Abstract]   [Full Text] [Related]  

  • 37. A high-throughput approach to protein structure analysis.
    Manjasetty BA; Shi W; Zhan C; Fiser A; Chance MR
    Genet Eng (N Y); 2007; 28():105-28. PubMed ID: 17153936
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution of glycolysis.
    Fothergill-Gilmore LA; Michels PA
    Prog Biophys Mol Biol; 1993; 59(2):105-235. PubMed ID: 8426905
    [No Abstract]   [Full Text] [Related]  

  • 39. Stability and characterization of human interleukin-1 beta.
    Gu L; Fausnaugh J
    Pharm Biotechnol; 1993; 5():221-48. PubMed ID: 8019695
    [No Abstract]   [Full Text] [Related]  

  • 40. Archival journal requirements for data deposition.
    Baker EN; Blundell TL; Vijayan M; Dodson E; Dodson G; Gilliland GL; Sussman JL
    Biophys J; 1996 Jun; 70(6):2994. PubMed ID: 8744337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.